On November 16, 2021 AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, reported that chairman and CEO Dr. Hans S. Keirstead will deliver a keynote at the Vaccine World Asia Congress (Press release, AIVITA Biomedical, NOV 16, 2021, View Source [SID1234595687]). The Singapore-based congress is being held virtually November 17-18. Dr. Keirstead’s speaking details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Keynote: A Fully Personalized COVID-19 Vaccine Made at Point-of-Care
When: Wednesday, November 17, 4:00 PM (GMT +8)
Location: Virtual – Singapore

In his keynote, Dr. Keirstead will share findings from AIVITA’s ongoing trials in COVID-19 and discuss the advantages of a personalized vaccine made at point-of-care.